Indicators for Quality Assessment of Hospitalized Ischemic Stroke Patients. A Study of the Efficacy of the Code Stroke in Spain
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 240
- Primary Endpoint
- Recovery rate of the Intravenous trombolysis treatment
Study Overview
Brief Summary
Code Stroke is a system for the rapid identification, pre-notification and transport of acute ischemic stroke patients. The objective of this study was to define quality indicators and to compare treatment outcomes in hospitals where Code Stroke has been implemented and hospitals without the use of Code Stroke (control patients).
Detailed Description
In a first step qualitative technique has been conducted to define treatment quality indicators of acute ischemic stroke patients. In a second step a prospective study is conducted to collect data of 240 inpatients from two groups of hospitals. Two hospitals applying Code Stroke (N= 120) and four hospitals non-applying Code Stroke procedure (N=120). A consecutive sampling method will be conducted. Inclusion criteria: acute ischemic stroke patients treated in the hospitals during the field study. The referral to the hospital could be from primary care, Emergency Unit of other hospital. Patients will enroll after inform consent.
A Singer-blind- research method will applied. Quality indicators defined in the first phase will be applied and comparisons will be realized using ANOVA.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 18 Years to 100 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •acute ischemic stroke in-patients
Exclusion Criteria
- •Patients who refuse participate
Arms & Interventions
Group A
Hospital using Code Stroke
Intervention: Code Stroke (Procedure)
Group B
Hospital not using Code Stroke
Outcomes
Primary Outcomes
Recovery rate of the Intravenous trombolysis treatment
Time Frame: 1 month
Number of patients showing an adequate recovery after Intravenous trombolysis treatment as assessed by the criteria of the Quality Indicator Board of the German Stroke Registers Study Group and the National Sentinel Audit of Stroke.
Secondary Outcomes
- Patient satisfaction(1 month)
- Mortality rates of the Intravenous trombolysis treatment(1 month)
- Treatment adequacy: Intravenous trombolysis treatment(1 month)
- Patient engage(1 month)
- response capacity(1 day)
- Patient safety. Complications in the recombinant tissue plasminogen activator treatment after tromobysis(1 month)
Investigators
José Joaquín Mira
Professor
Universidad Miguel Hernandez de Elche